A promise to look “five years younger” helped sell a £49 serum — until regulators asked the obvious question: where is the proof?

An advert for a Eucerin product has been banned after scrutiny of the claim that users could appear five years younger. Reports indicate the company based the statement on a study in which 160 people used the serum for four weeks and then said how much younger they believed they looked. That kind of self-assessment may sound persuasive in marketing copy, but it can quickly unravel when an ad crosses from aspiration into a measurable claim.

Beauty brands can sell hope, but once they put a number on it, they invite a much tougher test.

The case cuts to the heart of a long-running tension in the skincare business. Brands thrive on dramatic language, visual transformation, and the idea that time can bend with the right bottle on the bathroom shelf. But a claim tied to a specific result — especially one framed in years — demands evidence that regulators can treat as robust, objective, and reliable. Sources suggest that asking consumers how old they think they look after a month of use did not clear that bar.

Key Facts

  • The banned advert promoted a £49 Eucerin serum.
  • The disputed claim said users could look “five years younger.”
  • Eucerin asked 160 people to use the serum for four weeks.
  • The claim relied on participants saying how much younger they thought they looked.

The fallout matters beyond a single ad. The beauty industry leans heavily on before-and-after language, consumer perception studies, and carefully chosen phrases that imply scientific certainty without always delivering it. This ruling signals that regulators still draw a hard line between glowing testimonials and substantiated performance. For shoppers, it serves as a reminder that confidence and clinical proof do not mean the same thing.

What happens next matters for both marketers and consumers. Brands will likely scrutinize the wording of anti-ageing claims more closely, especially when they attach a precise number to a promised result. Regulators, meanwhile, may keep pressing for stronger evidence in a category built on ambition and image. The bigger question now sits in plain view: how many beauty claims survive when the spotlight shifts from persuasion to proof?